This International Women’s Day we’re taking a moment to acknowledge the many incredible women who are an unwavering force in the battle against CML. We proudly stand alongside the remarkable women who have dedicated their careers to advancing research, improving patient care, and raising awareness about CML.

Today we’re celebrating three of the amazing women we work with in Pakistan, China and Ghana as they tell us about their experiences as a woman working in CML, and their advice for other women in the field.

Dr. Mehreen Ali Khan, Pakistan

Dr. Mehreen Ali Khan is Consultant Haematologist at the Armed Forces Bone Marrow Transplant Centre in Rawalpindi, Pakistan. A leader in the field of Hematology, she is the Secretary/Treasurer of the Pakistan Society of Hematology and a great supporter of iCMLf, taking part in our Regional Discussion Groups and partnership meetings across Pakistan. She took some time to tell us about her experiences working in CML and her advice for other women in the field.

“In my 25 years working with CML, I've had some remarkable moments that have shaped my career. One of those moments happened when I joined Haematology. I encountered a case of a young woman with CML in chronic phase with lymph nodes, and LN biopsy with IHC revealed extra medullary lymphoid blast crisis. After induction with UK ALL protocol followed by consolidation and fully HLA matched sibling, Bone Marrow Transplant with 2 years of TKI, her life was saved. This experience ignited a deep interest and commitment to diagnosing and treating CML.

I've noticed the importance of a personal touch in medical care, especially for female patients in our culture. Colleagues and patients have entrusted me with the responsibility of treating female patients and conducting transplants when necessary. What strikes me most is the relief expressed by female Bone Marrow Transplant candidates after our interactions. It seems that having a female consultant who understands both the medical and emotional aspects of their needs makes a significant difference.

In my journey, I've taken pride in contributing to advancements in our field. I was part of a team that established crucial diagnostic tools like quantitative PCR for BCR ABL p210 and p190 and identified TKD mutations. Training at MD Anderson Cancer Center in Houston expanded my expertise, allowing me to contribute to innovative approaches like haploidentical BMT for CML.

One memorable highlight was participating in the iCMLf preceptorship program at MDACC with Prof Jorge Cortes in 2018. It was a high point in my career.

To my female colleagues in Haematology, I recommend considering a focus on CML. Treating CML is uniquely satisfying compared to acute Leukaemias, and the impact on pregnant women with CML is particularly heartwarming. Being part of safe deliveries and witnessing healthy outcomes is a rewarding aspect of our work.

Lastly, in the context of Bone Marrow Transplants for female CML patients, I advocate for female transplanters. It's not just about medical expertise; the empathy and understanding brought by female transplanters play a crucial role in the patient experience.”

Professor Qian JIANG, China

Professor Qian JIANG, M.D is Professor, Deputy Chair, Department of Hematology at Peking University People's Hospital, Peking University Institute of Hematology in Beijing, China. As well as being an expert in her field, she is a long-time supporter of iCMLf. 

“I have been working in the field of CML for 24 years. In 2002 I participated in a clinical trial of Gleevec for the treatment of CML and developed an interest. Later, in my clinical practice I discovered unanswered questions and gradually solved them, resulting in improved patient treatment outcomes. As a result, I felt a sense of professional achievement.

It’s hard being a woman in a largely male dominated field - I need to do more and do it better. Yet I am very proud of the recognition of my work by international peers and the trust from patients in my medical skills.

If you are a woman who wants to move into the field of CML or you’re struggling to make progress - please persist in doing what interests you, and enjoy the joy of success!”

Dr. Amma Benneh, Ghana

Dr. Amma Benneh is Head of Department/ Senior Lecturer/Consultant Haematologist at University of Ghana Medical School/Korle-Bu Teaching Hospital, in Ghana. She is a leading expert in CML and a long term friend of iCMLf, acting as one of our early preceptors. Dr. Benneh also sits on the iCMLf steering committee for the African Regional Discussion Groups. 

I entered the field of CML actively in 2007, after encountering CML cases in a general Haematology clinic since 2002. CML intrigued me with the effective treatment possibilities and cytogenetic responses achievable through oral medication, sparing patients from frequent hospital visits and the cosmetic effects of traditional IV medications. 

Being a woman in a predominantly male-dominated field has been both challenging and rewarding. The experience fuels my determination to surpass standard expectations, ensuring my contributions are recognised seriously. 

Reflecting on my career, I take pride in leading initiatives that have significantly impacted CML care. Spearheading the integration of molecular testing "In House" at our center has widened access to TKI, resulting in improved monitoring, better treatment outcomes, and saved lives. Sustaining the GIPAP program and initiating a Patient Support Group have brought immeasurable joy, fostering friendships and a robust support system among individuals facing the same condition. 

For aspiring women in the field or those facing obstacles, my advice mirrors the principles that have guided my journey: lots of hard work and determination, emphasis on teamwork and collaboration, and, above all, a genuine passion for and enjoyment of what you do.

We're proud to work with many amazing women all of the world, who are making a difference every day in the fight against CML. If you'd like to play your part in helping to drive research in CML, you can donate to iCMLf and help further our work to find a cure.